ISPOR Europe 2025
9 - 12 November
-
Modeling Methods and Practice
Sep 22, 2025, 16:24 -
Modernizing Medical Device Evaluation: Aligning Life-Cycle Evidence, HTA Methodologies, and Digital Support Tools
Sep 22, 2025, 16:24 -
Navigating Global Policy Shifts: Implications for Europe’s Pharmaceutical Pricing, Market Access, and HTA Landscape
Sep 22, 2025, 16:24 -
Implementing a Program for Early Feasibility Studies in Europe: Goldmine or Fool’s Gold?
Sep 22, 2025, 16:24 -
Measuring the Broader Impact of Health on Quality of Life and Productivity: Advances in Patient-Reported Outcomes and Economic Evaluation
Sep 22, 2025, 16:24 -
Transparent, Traceable, and Reliable Generative AI in HEOR: A Hands-on Workshop on Retrieval-Augmented Generation (RAG) For Evidence Generation
Sep 22, 2025, 16:24 -
Patient Experience Data for Evidence Generation to Support Regulatory and Access Decision Making
Sep 22, 2025, 16:24 -
Does Environmental Sustainability Warrant a Spot on ISPOR’s Value Flower: A Multistakeholder Debate
Sep 22, 2025, 16:24 -
COAs and Patient Preference Information: Building on a Promising but Challenging Relationship
Sep 22, 2025, 16:24 -
Is Transferring Evidence Across Europe a Herculean Task? The Opportunities and Challenges of Transportability Analyses in the Context of European Union Joint Clinical Assessments
Sep 22, 2025, 16:24 -
The Evidence Was There. So Why Didn’t It Matter?
Sep 22, 2025, 16:24 -
The Potential Impact of AI in Healthcare: MENA Region Perspectives
Sep 22, 2025, 16:24 -
Partnering for Progress: Advancing Patient-Centered Evidence in HEOR
Sep 22, 2025, 16:24 -
Lines of Therapy in Oncology Real-World Data: Navigating Complexity for Robust Evidence
Sep 22, 2025, 16:24 -
External Control Studies—What Does It Take to Get Real?
Sep 22, 2025, 16:24 -
Managed Entry Agreements: Can CEE Countries Mutualize Lessons Learned?
Sep 22, 2025, 15:24 -
AI in CEE Health System Decision Making: Can Payers, Patients, and Policy Align for Smarter Access?
Sep 22, 2025, 15:23 -
How Could Patient-Centric HTA Evolve in the Changing Global Pricing Landscape?
Sep 22, 2025, 15:12 -
Elevating HEOR Leadership: From Data Owner to Strategic Business Partner
Sep 22, 2025, 15:12 -
Survival at the Margins: Navigating HTA Challenges in Modern Oncology Trials
Sep 22, 2025, 15:12